Analyst firms · Citigroup · IRTC
Citigroup IRTC price target and rating history
iRhythm Holdings Inc. (IRTC) · Health Care
Citigroup rates iRhythm Holdings Inc. (IRTC) Neutral with a $124 price target, as of its latest action on Nov 6, 2026. It has published 5 rating actions on IRTC since December 2021, including 2 upgrades and 2 downgrades. Across 4 firms with a IRTC price target in the last 12 months, the median target is $160. Citigroup's $124 is 22% below that.
- Current rating
- Neutral
- Price target
- $124
- Median target, all firms
- $160
- Actions on IRTC
- 5
Citigroup price target on IRTC
Every Citigroup rating on IRTC
- Nov 6, 2026
- Dec 11, 2023
- Jun 9, 2022
- Jan 14, 2022
- Dec 15, 2021
How other firms rate IRTC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Citigroup | Neutral | $124 | Nov 6, 2026 |
| Piper Sandler | Overweight | $160 | Oct 16, 2026 |
| Stephens | Overweight | $160 | Jul 23, 2026 |
| Evercore ISI | Outperform | $210 | Jan 5, 2026 |
Questions about Citigroup and IRTC
- What is Citigroup's price target for IRTC?
- Citigroup's latest stated price target for iRhythm Holdings Inc. (IRTC) is $124, from its action on Nov 6, 2026.
- What is Citigroup's rating on IRTC?
- Citigroup rates IRTC Neutral, a neutral rating, as of Nov 6, 2026.
- When did Citigroup last change its view on IRTC?
- On Nov 6, 2026, Citigroup downgrades to Neutral from Buy, price target $124.
- How does Citigroup's IRTC target compare with other analysts?
- Across 4 firms with a IRTC price target in the last 12 months, the median target is $160. Citigroup's $124 is 22% below that.
More IRTC rating histories
All Citigroup ratingsIRTC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.